Zim Laboratories Ltd

NSE: ZIMLAB · BSE: 541400 · Pharmaceuticals & Biotechnology · 33 announcements

Share price: ₹146.61
Market cap: ₹786.7 Cr
Revenue (annual): ₹374.4 Cr
Net profit (annual): ₹5.84 Cr
P/E (TTM): 212.8×Sector 47.3×
Promoter holding: 30.36%+0.01% QoQ
FII holding: 0.03%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Employee Stock Options 6 Merger & Restructuring 5 Annual General Meeting 5 Earnings Call 4 Financial Results 3 Promoter Buying (Off-Market) 2 Board Meeting Date 2 Regulatory Approval 1 Other Announcement 1 Management Change 1 Business Update 1 Annual Report 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

6 Aug 2026 13:57 IST NSE

Financial Results

Zim Laboratories Q1 FY27 Results: Net Loss of ₹4 Cr, Loss Widens

Zim Laboratories Ltd reported revenue from operations of ₹94.2 Cr (+31.2% YoY) and a net loss of ₹4 Cr for Q1 FY27.

Key figure: Net loss ₹4 Cr

Open full results → Read the filing ↗

19 May 2026 16:42 IST NSE

Financial Results

Zim Laboratories Q4 FY26 Results: Net Profit ₹3.7 Cr, Down 24.5% YoY

Zim Laboratories Ltd reported revenue from operations of ₹105.3 Cr (-3.1% YoY) and net profit of ₹3.7 Cr (-24.5% YoY) for Q4 FY26.

Key figure: Net profit ₹3.7 Cr · -24.5% YoY

Open full results → Read the filing ↗

19 May 2026 16:41 IST NSE

Financial Results

Zim Laboratories Financial Results

Zim Laboratories reported annual consolidated total income of ₹385.78 Crore for FY26. The Board also appointed M/s Dhananjay V. Joshi & Associates as Cost Auditors.

Value: ₹385.8 Cr

Read the filing ↗